摘要
目的观察银杏达莫治疗急性缺血性脑血管病的临床疗效。方法选择98例缺血性脑血管病患者随机分为治疗组和对照组各49例,治疗组给予银杏达莫注射液20 mL加液体静滴,每日1次,14 d为一个疗程,;对照组用复方丹参注射液20 mL加液体静滴,每日1次,14 d为一个疗程,治疗14 d后观察比较治疗前后的血液流变学参数变化和神经功能缺损评分。结果治疗组神经功能缺损评分与对照组比较差异有统计学意义(P<0.05);治疗组有效率93.8%,对照组有效率79.6%,两组比较差异有统计学意义(P<0.05);治疗组血液流变学指标明显改善(P<0.05)。治疗过程中两组均未发生任何副反应。结论银杏达莫注射液治疗缺血性脑血管病有较好疗效,安全可靠。
Objective To verify the clinical effects of Ginkgo Dipyfidamole Injection on ischemic cerebrovascular disease. Methods The 98 cases with ischemic cerebrovascular disease were randomly divided into treatment group and control group, the treatment group （49 case） was given Ginkgo Dipyridamole Injection, once a day for 14 days. The control group （49 cases） was given Danshen Injection,also once a day for 14 days. The relative indexes between＇the two groups on blood hemorheology and Neurological Deficit Scores （NDS） were observed and compared before and after treatment. Results The total effective rate in treatment group （93.8%） was significantly higher than that of control group （79.6%） （P 〈 0.05）. Corn pared before and after treatment, the difference of neurological deficit scores and hemorheology between the two groups was significant （P 〈 0.05）. There were no adverse reactions. Conclusion Ginkgo Dipyridamole injection has a better clinical ef- fect in treating ischemic cerebrovascular disease.
出处
《中国现代医生》
2012年第16期128-129,共2页
China Modern Doctor
关键词
银杏达莫
缺血性脑血管病
血液流变学
Ginkgo Dipyridamole Injection
Ischemic cerebrovascular disease
Hemorrheology
